Dicot Investor Relations Material
Latest events
Investor Update
Dicot
Q1 2025
29 Apr, 2025
Investor Update
20 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Dicot
Access all reports
Dicot AB is a pharmaceutical company focused on the development of lifestyle drugs, primarily addressing sexual health issues such as erectile dysfunction and premature ejaculation. Founded in 2021, Dicot conducts drug discovery and development aimed at improving quality of life for patients with these conditions. The company's main research involves the drug candidate LIB-01, which is in the early stages of clinical trials. Dicot AB is a private entity and maintains active operations, contributing to the healthcare and drug development sectors. The company is headquartered in Uppsala, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Latest articles
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
Ticker symbol
DICOT
Country
🇸🇪 Sweden